Related references
Note: Only part of the references are listed.A rapid and simple screening method to identify conditions for enhanced stability of modular vaccine candidates
Alemu Tekewe et al.
BIOCHEMICAL ENGINEERING JOURNAL (2015)
Effect of hydrophobicity on protein-protein interactions
P. Chanphai et al.
EUROPEAN POLYMER JOURNAL (2015)
Effect of linker flexibility and length on the functionality of a cytotoxic engineered antibody fragment
Maximilian Klement et al.
JOURNAL OF BIOTECHNOLOGY (2015)
Insert engineering and solubility screening improves recovery of virus-like particle subunits displaying hydrophobic epitopes
R. S. Abidin et al.
PROTEIN SCIENCE (2015)
Synthetic biology design to display an 18 kDa rotavirus large antigen on a modular virus-like particle
Linda H. L. Lua et al.
VACCINE (2015)
Non-chromatographic preparation of a bacterially produced single-shot modular virus-like particle capsomere vaccine for avian influenza
Nani Wibowo et al.
VACCINE (2015)
The economics of virus-like particle and capsomere vaccines
Yap P. Chuan et al.
BIOCHEMICAL ENGINEERING JOURNAL (2014)
Bioengineering Virus-Like Particles as Vaccines
Linda H. L. Lua et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Energetic Changes Caused by Antigenic Module Insertion in a Virus-Like Particle Revealed by Experiment and Molecular Dynamics Simulations
Lin Zhang et al.
PLOS ONE (2014)
Bacterial co-expression of the α and β protomers of human L-asparaginase-3: Achieving essential N-terminal exposure of a catalytically critical threonine located in the β-subunit
Christos S. Karamitros et al.
PROTEIN EXPRESSION AND PURIFICATION (2014)
Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: Extending the potential of broadly cross-protecting epitopes
Nani Wibowo et al.
VACCINE (2014)
Fusion protein linkers: Property, design and functionality
Xiaoying Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Modular engineering of a microbially-produced viral capsomere vaccine for influenza
Nani Wibowo et al.
CHEMICAL ENGINEERING SCIENCE (2013)
Construction and Characterization of Virus-Like Particles: A Review
Andris Zeltins
MOLECULAR BIOTECHNOLOGY (2013)
Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)
Tania Rivera-Hernandez et al.
VACCINE (2013)
High-yield and scalable cell-free assembly of virus-like particles by dilution
Mervyn W. O. Liew et al.
BIOCHEMICAL ENGINEERING JOURNAL (2012)
Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions
Joseph M. Perchiacca et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Hepatitis E vaccine development A 14-year odyssey
Ting Wu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Contribution of Hydrophobic Interactions to Protein Stability
C. Nick Pace et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Capsomer Vaccines Protect Mice from Vaginal Challenge with Human Papillomavirus
Wai-Hong Wu et al.
PLOS ONE (2011)
Screening of genetic parameters for soluble protein expression in Escherichia coli
Erik Vernet et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
Production of protein complexes via co-expression
John J. Kerrigan et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
Anton P. J. Middelberg et al.
VACCINE (2011)
Virus-like particles in vaccine development
Antonio Roldao et al.
EXPERT REVIEW OF VACCINES (2010)
Microbial production of virus-like particle vaccine protein at gram-per-litre levels
Mervyn W. O. Liew et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
Subhashini Jagu et al.
VACCINE (2010)
Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs
Tilo Senger et al.
VACCINE (2010)
Refining HPV 16 L1 purification from E. coli: Reducing endotoxin contaminations and their impact on immunogenicity
Lysann Schaedlicha et al.
VACCINE (2009)
Quantitative analysis of virus-like particle size and distribution by field-flow Fractionation
Yap P. Chuan et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
High-level expression of soluble viral structural protein in Escherichia coli
Yap P. Chuan et al.
JOURNAL OF BIOTECHNOLOGY (2008)
Quaternary size distribution of soluble aggregates of glutathione-S-transferase-purified viral protein as determined by asymmetrical flow field flow fractionation and dynamic light scattering
Daniel I. Lipin et al.
JOURNAL OF CHROMATOGRAPHY A (2008)
Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha 2b fusion protein by linker engineering
Hong Liang Zhao et al.
PROTEIN EXPRESSION AND PURIFICATION (2008)
Enhancing the stability and solubility of TEV protease using in silico design
Lisa D. Cabrita et al.
PROTEIN SCIENCE (2007)
Comparative expression study to increase the solubility of cold adapted Vibrio proteins in Escherichia coli
Laila Niiranen et al.
PROTEIN EXPRESSION AND PURIFICATION (2007)
Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa
Saul R. Trevino et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Tandem copies of a human rotavirus VP8 epitope can induce specific neutralizing antibodies in BALB/c mice
Jennifer Kovacs-Nolan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levels
K Dell et al.
VACCINE (2006)
Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil (R))
M. Asif A. Siddiqui et al.
DRUGS (2006)
Improved stability and yield of Fv targeted superantigen by introducing both linker and disulfide bond into the targeting moiety
HJ Hao et al.
BIOCHIMIE (2005)
Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli
S Idicula-Thomas et al.
PROTEIN SCIENCE (2005)
Early events in protein aggregation: Molecular flexibility and hydrophobicity/charge interaction in amyloid peptides as studied by molecular dynamics simulations
M Valerio et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus
J Kovacs-Nolan et al.
BIOCHEMICAL JOURNAL (2003)
Recombinant hepatitis B vaccine (Engerix-B (R)) - A review of its immunogenicity and protective efficacy against hepatitis B
GM Keating et al.
DRUGS (2003)
Increasing protein stability by polar surface residues: Domain-wide consequences of interactions within a loop
PR Pokkuluri et al.
BIOPHYSICAL JOURNAL (2002)
Immunization with a pentameric L1 fusion protein protects against papillomavirus infection
H Yuan et al.
JOURNAL OF VIROLOGY (2001)
Expression and membrane association of hepatitis C virus envelope 1 protein
AR Ciccaglione et al.
VIRUS GENES (2000)
Production of polyomavirus structural protein VP1 in yeast cells and its interaction with cell structures
Z Palková et al.
FEBS LETTERS (2000)
Share Paper
